Clinical Trial Update: Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and Cisplatin [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating gene expression profiling in invasive bladder cancer patients treated with methotrexate, vinblastine, doxorubicin, and cispl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Doxorubicin (doxorubicin)
• METHOTREXATE (METHOTREXATE)
• Vinblastine (vinblastine)

Snippet

Sponsor: Kyoto University | Conditions: Bladder Cancer | Phase 2 | Status: TERMINATED